The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels

Cell Rep. 2017 Oct 31;21(5):1331-1346. doi: 10.1016/j.celrep.2017.10.029.

Abstract

Mechanistic (or mammalian) target of rapamycin complex 1 (mTORC1) integrates signals from growth factors and nutrients to control biosynthetic processes, including protein, lipid, and nucleic acid synthesis. We find that the mTORC1 pathway is responsive to changes in purine nucleotides in a manner analogous to its sensing of amino acids. Depletion of cellular purines, but not pyrimidines, inhibits mTORC1, and restoration of intracellular adenine nucleotides via addition of exogenous purine nucleobases or nucleosides acutely reactivates mTORC1. Adenylate sensing by mTORC1 is dependent on the tuberous sclerosis complex (TSC) protein complex and its regulation of Rheb upstream of mTORC1, but independent of energy stress and AMP-activated protein kinase (AMPK). Even though mTORC1 signaling is not acutely sensitive to changes in intracellular guanylates, long-term depletion of guanylates decreases Rheb protein levels. Our findings suggest that nucleotide sensing, like amino acid sensing, enables mTORC1 to tightly coordinate nutrient availability with the synthesis of macromolecules, such as protein and nucleic acids, produced from those nutrients.

Keywords: AMPK; ATP; GTP; Rag GTPases; Rheb; mTOR; nucleotides; nutrient sensing; purine; tuberous sclerosis complex.

MeSH terms

  • A549 Cells
  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Cell Line
  • Dihydroorotate Dehydrogenase
  • Enzyme Inhibitors / pharmacology
  • Fluorouracil / pharmacology
  • HeLa Cells
  • Humans
  • Mechanistic Target of Rapamycin Complex 1 / metabolism*
  • Mercaptopurine / pharmacology
  • Methotrexate / pharmacology
  • Mice
  • Oxidoreductases Acting on CH-CH Group Donors / antagonists & inhibitors
  • Oxidoreductases Acting on CH-CH Group Donors / genetics
  • Oxidoreductases Acting on CH-CH Group Donors / metabolism
  • Phosphoribosylglycinamide Formyltransferase / antagonists & inhibitors
  • Phosphoribosylglycinamide Formyltransferase / genetics
  • Phosphoribosylglycinamide Formyltransferase / metabolism
  • Purine Nucleotides / metabolism*
  • RNA Interference
  • Ribosomal Protein S6 Kinases, 70-kDa / metabolism
  • Signal Transduction / drug effects
  • Thymidylate Synthase / antagonists & inhibitors
  • Thymidylate Synthase / genetics
  • Thymidylate Synthase / metabolism
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins / antagonists & inhibitors
  • Tumor Suppressor Proteins / genetics
  • Tumor Suppressor Proteins / metabolism

Substances

  • Dihydroorotate Dehydrogenase
  • Enzyme Inhibitors
  • Purine Nucleotides
  • Tuberous Sclerosis Complex 2 Protein
  • Tumor Suppressor Proteins
  • Mercaptopurine
  • Oxidoreductases Acting on CH-CH Group Donors
  • Thymidylate Synthase
  • Phosphoribosylglycinamide Formyltransferase
  • Mechanistic Target of Rapamycin Complex 1
  • Ribosomal Protein S6 Kinases, 70-kDa
  • AMP-Activated Protein Kinases
  • Fluorouracil
  • Methotrexate